Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on April 14, 2025
Applied Digital Reports Fiscal Third Quarter 2025 Results
GlobeNewswire
·
April 14, 2025
DALLAS, April 14, 2025 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) ("Applied Digital" or the "Company"), a designer, builder, and operator of next-generation digital infrastructure designed for high-performance computing (“HPC”) …
Rygen Technologies named one of Inbound Logistics’ Top 100 Logistics and Supply Chain Technology Providers
GlobeNewswire
·
April 14, 2025
GREENVILLE, S.C., April 14, 2025 (GLOBE NEWSWIRE) -- Inbound Logistics, a supply chain and logistics publication focused on providing education and guidance to enterprise leaders in the industry, named Rygen Technologies as one of the Top 100 Logistics and …
DIAGNOS Provides Additional Information on Amendment to Convertible Debentures
GlobeNewswire
·
April 14, 2025
BROSSARD, Quebec, April 14, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of certain ophthalmic health issues using advanced technology based on Artificial …
VeeMost Technologies Inc Announces Corporate Name, Ticker Symbol, and CUSIP change
GlobeNewswire
·
April 14, 2025
Red Bank, NJ, April 14, 2025 (GLOBE NEWSWIRE) -- VeeMost Technologies Inc. (OTC: VMST), a leading provider of cutting-edge IT solutions, is pleased to announce that the Financial Industry Regulatory Authority (FINRA) has approved the Company’s official …
Can-Fite Announces $3.0 Million Registered Direct Offering of American Depositary Shares
GlobeNewswire
·
April 14, 2025
RAMAT GAN, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and inflammatory diseases (“Can-Fite” or the …
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald
GlobeNewswire
·
April 14, 2025
WARREN, N.J., April 14, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announces CEO Dr. Ryan Saadi, MD, MPH, will participate in BioNJ’s Fifteenth Annual Bio Partnering Conference. Dr. Saadi will be …
Hartcoin, The Most Profitable Cloud Mining Platform: Passive Income Made Effortless
GlobeNewswire
·
April 14, 2025
London,UK , April 14, 2025 (GLOBE NEWSWIRE) -- Crypto investors everywhere are feeling the tremors, with fear firmly gripping traders across the entire crypto market. The CoinMarketCap Crypto Fear and Greed Index has been locked in Fear to Extreme Fear …
BNBEX Launches High-Precision Trading Signal Index, Empowering Global Investors Through Compliant Innovation
GlobeNewswire
·
April 14, 2025
MIAMI, FL, April 14, 2025 (GLOBE NEWSWIRE) -- As the global digital asset trading market matures, investors are becoming increasingly selective in choosing trading platforms. Beyond profitability, regulatory compliance, team income potential, user …
VivoPower provides clarification re US$180 million enterprise value takeover proposal
GlobeNewswire
·
April 14, 2025
Proportional takeover offer is a buyout for 8 out of 10 shares held by shareholders at a record date Amount to be offered per share to be computed as US$180m less net debt divided by number of eligible ordinary shares at the time LONDON, April 14, 2025 ( …
AB Science receives notice of allowance for Unites States patent covering masitinib until 2040 in the treatment of sickle cell disease
GlobeNewswire
·
April 14, 2025
PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL DISEASE Paris, April 14, 2025, 6pm CET AB Science SA (Euronext - FR0010557264 - AB) today announced that the United …
AB Science reçoit un avis d’acceptation pour le brevet américain courant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose
GlobeNewswire
·
April 14, 2025
COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS D'ACCEPTATION POUR LE BREVET AMERICAIN COUVRANT JUSQU'EN 2040 LE MASITINIB DANS LE TRAITEMENT DE LA DREPANOCYTOSE Paris, 14 avril 2025, 18h AB Science SA (Euronext - FR0010557264 - AB) annonce aujourd'hui que …
YC-Backed Startup Octolane Raises Seed Round to Challenge Salesforce with the First Self-Driving AI CRM That Automates Sales Actions and Manual CRM Updates
GlobeNewswire
·
April 14, 2025
SAN FRANCISCO, April 14, 2025 (GLOBE NEWSWIRE) -- Octolane, which provides the first AI-driven CRM that automates sales actions and CRM updates, announced today an oversubscribed $2.6M seed round. Founded by two young immigrants, Octolane is challenging …
Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Connection with the Proposed Merger with Tvardi Therapeutics
GlobeNewswire
·
April 14, 2025
STAMFORD, Conn., April 14, 2025 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) (the “Company”), today announced that its Board of Directors (the “Board”) has approved a 1-for-3 reverse stock split of its outstanding shares of common stock. Cara …
Valneva Receives First Marketing Authorization for IXCHIQ® in a Chikungunya Endemic Country
GlobeNewswire
·
April 14, 2025
Saint Herblain (France), April 14, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted marketing authorization to its single-dose vaccine IXCHIQ …
Valneva reçoit la première autorisation de mise sur le marché pour IXCHIQ® dans un pays où le chikungunya est endémique
GlobeNewswire
·
April 14, 2025
Saint Herblain (France), le 14 avril 2025 - Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que l'agence de santé brésilienne (ANVISA) a accordé l'autorisation de mise sur le marché à son …
Blockgraph and the 4As Partner to Release New Research About the Power of Household Identity in the New TV Era
GlobeNewswire
·
April 14, 2025
NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Blockgraph, the privacy-first data collaboration platform designed to fuel the future of connected TV advertising, and the American Association of Advertising Agencies (“the 4As”) today announced the release of …
ClimateTech Connect 2025 Kicks Off Tomorrow: The Industry’s Top Leaders Converge to Shape the Future of Climate Innovation
GlobeNewswire
·
April 14, 2025
WASHINGTON, April 14, 2025 (GLOBE NEWSWIRE) -- With global climate events on the rise and resilience at the forefront of the minds of industries across the board, ClimateTech Connect 2025 officially kicks off tomorrow, Tuesday, April 15. The event brings …
American Rebel Beer Named Entitlement Sponsor For the American Rebel Light NHRA 4-Wide Nationals
GlobeNewswire
·
April 14, 2025
Ahead of zMAX Dragway’s April showcase of speed, American Rebel Beer has been named entitlement sponsor for the American Rebel Light NHRA 4-Wide Nationals Tickets for the April 25-27 spectacle are on sale at www.charlottemotorspeedway.com CONCORD, N.C., …
Wellamoon Reviews: Do Not Spend A Dime Till Have This Eyeopener Report!
GlobeNewswire
·
April 14, 2025
FRANKLIN SQUARE, N.Y., April 14, 2025 (GLOBE NEWSWIRE) -- Wellamoon emerged as a cutting-edge sleep solution formulated for those looking for a natural pathway to revitalized rest. Designed with improved transdermal technology, these sleep patches leverage …
Prostadine Drops Reviews [We Tested It] Read Ingredients, Side Effects for Urinary System
GlobeNewswire
·
April 14, 2025
ST. PETERSBURG, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- Prostadine The Natural Solution for Prostate Health - As men age, prostate health often becomes a significant concern. The prostate, a small, walnut-sized gland in the male reproductive system, plays …